Home Ionis Pharmaceuticals

Ionis Pharmaceuticals

In operation
Post-IPO Round
RNA Drug Developer
Basic
Enterprise Profile

Basic Information

Ionis Pharmaceuticals is a leading company in the field of RNA-targeted drug discovery and development, with a first-class or best-in-class drug pipeline that has the potential to deliver high value to patients with serious unmet medical needs. The company has created an efficient and broadly applicable drug discovery platform. Ionis currently has three marketed drugs and a major late-stage pipeline, highlighted by industry-leading neurology and cardiometabolic franchises. Our scientific innovation begins and continues with the recognition that patients depend on us, driving our vision to become one of the most successful biotechnology companies.
Ionis Pharmaceuticals, Inc.
California,United States of America
101~500 people
January 01, 1989
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Targeted Technology
Concept
Disease Treatment Metabolic Diseases # Nervous System Diseases # Liver Cancer
Application Scenarios
Targeted drugs Innovative Drugs Small Nucleic Acid Drugs